Viprinex TM ancrod

Related by string. * : Viprinex . Viprinex TM . candidate Viprinex TM / TMD . Tm . TMs . TMS . tm : FinancialWire tm website . Contact FinancialWire tm . TM EA SPORTS . Forrester Wave TM . Ibis T# TM Biosensor . Xerox Phaser TM . Addressing Psoriasis TM . Nintendo GameCube TM . Citrix Synergy TM . through eReleases TM . Impart IQ TM . AMD Opteron TM . ICO mim TM . Onko Sure TM / ANCRO . Ancrod : ancrod * *

Related by context. Frequent words. (Click for all words.) 55 Viprinex 55 Panzem R 55 Desmoteplase 55 eniluracil 54 forodesine 54 acute decompensated heart 54 Bicifadine 54 Zerenex 54 anti thrombotic 53 cangrelor 53 atacicept 53 secondary hyperparathyroidism 53 Cetrorelix 53 Amrubicin 52 antithrombotic 52 Icatibant 52 Mipomersen 52 ixabepilone 52 MKC# 52 Pivotal Trial 52 Pivotal Phase 52 Pivotal Phase III 52 liposomal formulation 52 desmoteplase 52 DP b# 51 belinostat 51 octreotide 51 methylnaltrexone 51 vernakalant 51 injectable formulation 51 Phase III Trial 51 zileuton 51 BAY #-# 51 R sorafenib tablets 50 pertuzumab 50 Staccato loxapine 50 Nexavar ® 50 mTOR inhibitor 50 NPSP# 50 Aerosurf 50 phase IIb 50 otelixizumab 50 MOZOBIL 50 tezampanel 50 almorexant 50 Combidex 50 multi kinase inhibitor 50 patients undergoing percutaneous 50 Lexiscan 50 Lenalidomide 50 epothilone 50 acute ischemic stroke 50 Asentar 50 teplizumab 50 Allovectin 7 R 49 Amigal 49 Celator 49 Angiox 49 opioid tolerant patients 49 Integrilin 49 Orphan Drug status 49 sapacitabine 49 thrombolytics 49 Droxidopa 49 Urocidin 49 Genasense R oblimersen 49 NYHA Class II 49 metastatic hormone refractory 49 Zelrix 49 hematological malignancies 49 partial agonist 49 MicroDose 49 opioid induced constipation 49 pulmonary arterial hypertension PAH 49 multiple myeloma MM 49 Phase III Clinical Trial 49 Menerba 49 KRN# 49 registrational trial 49 Amphotericin B 48 Alemtuzumab 48 neuroprotection 48 OXi# 48 Tesetaxel 48 alfimeprase 48 platelet inhibition 48 Factor IX 48 Dasatinib 48 Phase IIb trials 48 Epratuzumab 48 Stedivaze 48 temsirolimus 48 daclizumab 48 Herceptin trastuzumab 48 alvimopan 48 phase IIb clinical 48 ICA # 48 ZFP Therapeutic 48 IPX# 48 Rebif ® 48 QRxPharma

Back to home page